[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 500,0401\nHeart failure with reduced ejection fraction\nN = 412,3351\np-value2\n\n\n\n\nAge, y\n73 (13)\n70 (14)\n&lt;0.001\n\n\nSex\n\n\n\n\n&lt;0.001\n\n\n    Female\n316,165 (63%)\n180,465 (44%)\n\n\n\n\n    Male\n183,855 (37%)\n231,860 (56%)\n\n\n\n\nRace\n\n\n\n\n&lt;0.001\n\n\n    White\n340,015 (69%)\n249,740 (62%)\n\n\n\n\n    Asian or Pacific Islander\n9,730 (2.0%)\n8,060 (2.0%)\n\n\n\n\n    Black\n90,820 (19%)\n98,275 (24%)\n\n\n\n\n    Hispanic\n36,030 (7.4%)\n34,635 (8.6%)\n\n\n\n\n    Native American\n2,905 (0.6%)\n2,775 (0.7%)\n\n\n\n\n    Other\n10,315 (2.1%)\n10,120 (2.5%)\n\n\n\n\nElixhauser comorbidity index\n7.97 (1.97)\n7.93 (2.03)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n154,595 (31%)\n141,855 (35%)\n\n\n\n\n    $52,000 - $65,999\n132,230 (27%)\n107,925 (27%)\n\n\n\n\n    $66,000 - $87,999\n116,365 (24%)\n89,575 (22%)\n\n\n\n\n    $88,000 or more\n90,095 (18%)\n64,990 (16%)\n\n\n\n\nHospital bed size\n\n\n\n\n&lt;0.001\n\n\n    Large\n244,880 (49%)\n218,925 (53%)\n\n\n\n\n    Medium\n144,725 (29%)\n111,865 (27%)\n\n\n\n\n    Small\n110,435 (22%)\n81,545 (20%)\n\n\n\n\nHospital location/teaching status\n\n\n\n\n&lt;0.001\n\n\n    Rural\n45,190 (9.0%)\n31,910 (7.7%)\n\n\n\n\n    Urban, non-teaching\n88,730 (18%)\n67,280 (16%)\n\n\n\n\n    Urban, teaching\n366,120 (73%)\n313,145 (76%)\n\n\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n    Private\n56,670 (11%)\n59,485 (14%)\n\n\n\n\n    Medicaid\n41,590 (8.3%)\n53,060 (13%)\n\n\n\n\n    Medicare\n394,410 (79%)\n291,455 (71%)\n\n\n\n\n    Other\n7,000 (1.4%)\n7,915 (1.9%)\n\n\n\n\nHospital region\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n143,115 (29%)\n110,775 (27%)\n\n\n\n\n    Northeast\n97,800 (20%)\n69,985 (17%)\n\n\n\n\n    South\n182,320 (36%)\n159,240 (39%)\n\n\n\n\n    West\n76,805 (15%)\n72,335 (18%)\n\n\n\n\nHypertension\n460,555 (92%)\n370,895 (90%)\n&lt;0.001\n\n\nHyperlipidemia\n287,495 (57%)\n233,485 (57%)\n&lt;0.001\n\n\nPeripheral vascular disease\n64,540 (13%)\n99,435 (24%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n225,895 (45%)\n154,690 (38%)\n&lt;0.001\n\n\nCoronary artery disease\n211,005 (42%)\n233,360 (57%)\n&lt;0.001\n\n\nDementia\n51,595 (10%)\n34,315 (8.3%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n248,555 (50%)\n206,545 (50%)\n0.11\n\n\nValvular heart disease\n135,015 (27%)\n120,545 (29%)\n&lt;0.001\n\n\nAtrial fibrillation\n190,110 (38%)\n155,520 (38%)\n0.2\n\n\nBMI\n\n\n\n\n&lt;0.001\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n24,750 (15%)\n18,945 (18%)\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n25,370 (16%)\n16,480 (16%)\n\n\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n76,400 (47%)\n35,780 (34%)\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n9,745 (6.0%)\n9,595 (9.1%)\n\n\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n11,150 (6.9%)\n9,770 (9.2%)\n\n\n\n\n    Underweight (BMI ≤19.9kg/m²)\n14,105 (8.7%)\n15,100 (14%)\n\n\n\n\nPresence of pacemaker\n42,770 (8.6%)\n79,730 (19%)\n&lt;0.001\n\n\nprevious MI\n54,260 (11%)\n81,165 (20%)\n&lt;0.001\n\n\nPior cardiac surgery\n67,020 (13%)\n74,840 (18%)\n&lt;0.001\n\n\nDepression\n91,320 (18%)\n62,600 (15%)\n&lt;0.001\n\n\nCancer\n30,500 (6.1%)\n24,545 (6.0%)\n0.2\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 500,0401\nHeart failure with reduced ejection fraction\nN = 412,3351\np-value2\n\n\n\n\nDied during hospitalization\n15,235 (3.0%)\n16,220 (3.9%)\n&lt;0.001\n\n\nLength of stay (days)\n7.0 (7.2)\n7.6 (8.7)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n76,088 (99,221)\n94,365 (158,543)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test\n\n\n\n\n\n\n\n\n\nMultivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n1.47\n1.32, 1.63\n&lt;0.001\n\n\nAge, y\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.23\n1.10, 1.36\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.99\n0.66, 1.48\n&gt;0.9\n\n\n    Black\n0.91\n0.79, 1.05\n0.2\n\n\n    Hispanic\n0.90\n0.73, 1.11\n0.3\n\n\n    Native American\n0.69\n0.28, 1.70\n0.4\n\n\n    Other\n1.17\n0.84, 1.62\n0.4\n\n\nElixhauser comorbidity index\n1.30\n1.26, 1.35\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.91\n0.79, 1.04\n0.2\n\n\n    $66,000 - $87,999\n0.88\n0.77, 1.02\n0.090\n\n\n    $88,000 or more\n0.92\n0.78, 1.08\n0.3\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.84\n0.67, 1.05\n0.13\n\n\n    Medicare\n0.85\n0.72, 1.01\n0.066\n\n\n    Other\n1.36\n0.95, 1.95\n0.091\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.07\n0.91, 1.26\n0.4\n\n\n    South\n0.97\n0.85, 1.11\n0.6\n\n\n    West\n0.87\n0.73, 1.04\n0.13\n\n\nHospital bed size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.97\n0.85, 1.09\n0.6\n\n\n    Small\n0.87\n0.76, 1.00\n0.053\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.88\n0.71, 1.09\n0.3\n\n\n    Urban, teaching\n0.89\n0.74, 1.08\n0.2\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.52\n0.44, 0.61\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.66, 0.82\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.69, 0.93\n0.003\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.75, 0.95\n0.005\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.64, 0.79\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.69, 0.88\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.92, 1.29\n0.3\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.90, 1.32\n0.4\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.05\n1.80, 2.34\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.85, 1.07\n0.4\n\n\nBMI\n\n\n\n\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n—\n—\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n0.85\n0.69, 1.05\n0.14\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n1.30\n1.10, 1.54\n0.002\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n1.63\n1.32, 2.02\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n1.27\n1.02, 1.58\n0.033\n\n\n    Underweight (BMI ≤19.9kg/m²)\n2.13\n1.77, 2.56\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.66, 0.93\n0.007\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.88, 1.23\n0.6\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.59, 0.79\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.80, 1.12\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\n\nMultivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n0.62\n0.47, 0.77\n&lt;0.001\n\n\nAge, y\n-0.01\n-0.02, 0.00\n0.002\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.41\n0.26, 0.56\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.56\n-0.28, 1.4\n0.2\n\n\n    Black\n-0.05\n-0.24, 0.15\n0.6\n\n\n    Hispanic\n-0.11\n-0.39, 0.18\n0.5\n\n\n    Native American\n0.04\n-0.73, 0.81\n&gt;0.9\n\n\n    Other\n0.31\n-0.33, 0.95\n0.3\n\n\nElixhauser comorbidity index\n0.61\n0.55, 0.66\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.18\n-0.36, 0.00\n0.047\n\n\n    $66,000 - $87,999\n-0.07\n-0.27, 0.14\n0.5\n\n\n    $88,000 or more\n0.17\n-0.10, 0.43\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.08\n-0.24, 0.39\n0.6\n\n\n    Medicare\n-0.21\n-0.45, 0.02\n0.074\n\n\n    Other\n0.10\n-0.49, 0.68\n0.7\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.1\n0.82, 1.4\n&lt;0.001\n\n\n    South\n0.50\n0.29, 0.72\n&lt;0.001\n\n\n    West\n-0.44\n-0.73, -0.16\n0.002\n\n\nHospital bed size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.93\n-1.1, -0.73\n&lt;0.001\n\n\n    Small\n-1.3\n-1.6, -1.1\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.2\n0.88, 1.5\n&lt;0.001\n\n\n    Urban, teaching\n1.9\n1.6, 2.1\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.4, -0.85\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.71\n-0.86, -0.57\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.12\n-0.34, 0.11\n0.3\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.12\n-0.27, 0.03\n0.10\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.80\n-0.96, -0.65\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.34\n-0.52, -0.16\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.34\n0.06, 0.61\n0.015\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.36\n0.04, 0.68\n0.027\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.0\n1.9, 2.2\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.01\n-0.14, 0.17\n0.9\n\n\nBMI\n\n\n\n\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n—\n—\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-0.25\n-0.46, -0.03\n0.023\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n0.60\n0.40, 0.81\n&lt;0.001\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n1.2\n0.85, 1.5\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n0.76\n0.45, 1.1\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n1.4\n1.1, 1.7\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.84\n-1.1, -0.62\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.44\n-0.62, -0.25\n&lt;0.001\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.23\n-0.44, -0.03\n0.023\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.67\n-0.85, -0.50\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n13,750\n11,168, 16,332\n&lt;0.001\n\n\nAge, y\n-590\n-721, -459\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,029\n3,808, 8,250\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n23,569\n7,291, 39,847\n0.005\n\n\n    Black\n-3,864\n-6,855, -873\n0.011\n\n\n    Hispanic\n15,227\n9,762, 20,691\n&lt;0.001\n\n\n    Native American\n-13,994\n-23,057, -4,930\n0.002\n\n\n    Other\n23,412\n6,135, 40,688\n0.008\n\n\nElixhauser comorbidity index\n8,064\n6,932, 9,195\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-1,380\n-4,131, 1,371\n0.3\n\n\n    $66,000 - $87,999\n-842\n-4,104, 2,419\n0.6\n\n\n    $88,000 or more\n6,582\n1,976, 11,188\n0.005\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-9,073\n-14,471, -3,675\n&lt;0.001\n\n\n    Medicare\n-4,851\n-9,140, -562\n0.027\n\n\n    Other\n1,729\n-9,009, 12,468\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n23,908\n17,510, 30,305\n&lt;0.001\n\n\n    South\n14,541\n10,951, 18,131\n&lt;0.001\n\n\n    West\n39,902\n33,292, 46,512\n&lt;0.001\n\n\nHospital bed size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-13,601\n-17,664, -9,537\n&lt;0.001\n\n\n    Small\n-21,409\n-25,331, -17,487\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n26,467\n22,521, 30,413\n&lt;0.001\n\n\n    Urban, teaching\n36,641\n33,263, 40,018\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-20,381\n-25,338, -15,425\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,303\n-4,505, -102\n0.040\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,184\n-4,733, 2,366\n0.5\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8,328\n5,968, 10,689\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,068\n-12,434, -7,702\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,974\n885, 7,064\n0.012\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,237\n-8,550, -1,924\n0.002\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,318\n-972, 7,608\n0.13\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n22,083\n19,805, 24,362\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-36\n-2,504, 2,433\n&gt;0.9\n\n\nBMI\n\n\n\n\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n—\n—\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-4,917\n-8,363, -1,471\n0.005\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n-533\n-3,740, 2,674\n0.7\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n8,246\n3,313, 13,178\n0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n8,454\n3,505, 13,402\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n11,386\n6,447, 16,325\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-13,286\n-17,205, -9,368\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,786\n-13,654, -7,919\n&lt;0.001\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,961\n-13,572, -8,350\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16,717\n-19,664, -13,771\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]